
USPTO Releases Verdict on CRISPR Patent
February 22, 2017The U.S. Patent and Trademark Office (USPTO) released its decision on the issue of intellectual property rights to the gene-editing technique, CRISPR-Cas9. USPTO ruled that the Broad Institute of Harvard and the Massachusetts Institute of Technology in Cambridge could keep their patents on using the technique in eukaryotic cells. This means that University of California, Berkeley, has lost their battle over the rights to CRISPR.
The battle started in 2012 when Jennifer Doudna and colleagues at Berkeley outlined how CRISPR could be used to precisely cut isolated DNA. The following year, Feng Zhang and colleagues at Broad Institute showed how CRISPR can be adapted to edit DNA in eukaryotic cells. According to Nature, the battle is not yet over because Berkeley can still appeal the ruling in the U.S. Furthermore, the same parties applied for patent in Europe and no decision has been announced to date.
Read more about this in Nature.
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
COVID-19 Alerts
- Development of Targeted Mutant Rice using the CRISPR-Cpf1 System
- USPTO Releases Verdict on CRISPR Patent
- Fat Content in Soybean Oil Modified with CRISPR-Cpf1
-
News from Around the World
- Climate-smart Rice Helps Farmers Face Climate Change
- Public learns about GMOs at ‘Harvest Money' Expo in Uganda
- Australian OGTR Approves Field Trial of GM Potato
-
Research Highlights
- Downregulation of BnDA1 Improves Seed Weight and Organ Size in Oilseed Rape
- Overexpression of Wheat Gene TaOEP16-2-5B Enhances Heat and Drought Tolerance in Arabidopsis
-
Plant Breeding Innovations
- Development of Targeted Mutant Rice using the CRISPR-Cpf1 System
- USPTO Releases Verdict on CRISPR Patent
- Fat Content in Soybean Oil Modified with CRISPR-Cpf1
- Penicillin Production in Penicillium chrysogenum is not Dependent on the Number of Synthesis Genes
-
Beyond Crop Biotech
- Penicillin Production in Penicillium chrysogenum is not Dependent on the Number of Synthesis Genes
-
From the BICs
- Helsinki and Cairo Universities Collaborate to Advance Science
-
Announcements
- The GMO MOOC is Back!
- MSU Training Program on IPR and Technology Commercialization
- IPBO-VIB-UGent Course "Modern Breeding Techniques of Maize"
-
Resources
- New ISAAA Board Game: #BiotechisCool
- New Communication Materials from Cornell Alliance for Science
-
Read the latest: - Crop Biotech Update (January 25, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
-
Subscribe to CBU: - Share
- Tweet